Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Long-Term Investments (2024 - 2026)

Invivyd's (IVVD) quarterly Long-Term Investments came in at $25.3 million in Q2 2026, little changed on a YoY basis from $25.4 million in Q2 2025, and down 0.6% quarter-over-quarter from $25.5 million in Q4 2025.

Analysis

Invivyd (IVVD) Long-Term Investments (2024 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Long-Term Investments for 3 consecutive years, with $25.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Investments changed 0.37% year-over-year to $25.3 million; the trailing twelve-month figure through Jun 2026 stood at $25.3 million (changed 0.37% YoY), and the FY2025 full-year result was $25.5 million, down 1.57% from the prior year.
  • Long-Term Investments slipped to $25.3 million in Q2 2026 per IVVD's latest filing, from $25.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $25.9 million in Q4 2024 and bottomed at $25.3 million in Q2 2026.
  • Historically, Long-Term Investments has averaged $25.5 million across 3 years, with a median of $25.4 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Long-Term Investments fell 1.57% in 2025, then dropped 0.37% in 2026.
  • Over 3 years, Long-Term Investments stood at $25.9 million in 2024, then dropped by 1.57% to $25.5 million in 2025, then fell by 0.6% to $25.3 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $25.3 million, $25.5 million, and $25.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 5.79 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 9.83 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -4.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 1.77 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 22.17 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 25.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.35 Mn
Dec 31, 2025 25.50 Mn
Sep 30, 2025 25.40 Mn
Jun 30, 2025 25.44 Mn
Mar 31, 2025 25.42 Mn
Dec 31, 2024 25.91 Mn